Text Size
M
L
Language
JP
EN
About TEIKOKU SEIYAKU
About TEIKOKU SEIYAKU
VISION2031
Patch Medication, Globally
For a World Without Pain
Hydrohesive®
A Familiar Company, Teikoku Seiyaku
International Focus
Plant
Laboratory
Teikoku Seiyaku Group
Locations
Company
Company
Message
Corporate Philosophy
Company Overview
Office Locations
History
Contact us
News release
HOME
NEWS
2023.6.29
President and CEO Misako Fujioka Interviewed in Newsweek International
2023.3.28
Change in The Board of Directors
2023.3.15
Notice of Launch of ALLYDONE® Patches 27.5 mg / ALLYDONE® Patches 55 mg in Japan as Japan’s First Donepezil Transdermal Therapeutic System
Page Top
